Position in NVS
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$2,499,906
+$759,436 QoQ
Shares Held
16,366
+29.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parallel Advisors, LLC holds $104,513,791 across 18 Drug Manufacturers - General names. NVS ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,405 | $27,965,606 | |
| 2 | ABBV |
AbbVie Inc.
|
103,875 | $22,591,773 | |
| 3 | JNJ |
Johnson & Johnson
|
80,406 | $19,654,442 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
75,984 | $10,589,890 | |
| 5 | MRK |
Merck & Co., Inc.
|
56,169 | $6,756,569 | |
| 6 | PFE |
Pfizer Inc
|
129,199 | $3,627,907 | |
| 7 | AMGN |
Amgen Inc
|
10,183 | $3,582,888 | |
| 8 | NVS |
Novartis AG
This page
|
16,366 | $2,499,906 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,499,906 | 16,366 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,740,470 | 12,624 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,599,922 | 12,476 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,467,246 | 12,125 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,430,399 | 12,831 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,402,918 | 14,417 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $1,601,193 | 13,921 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,378,231 | 12,946 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $1,165,596 | 12,050 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $895,704 | 8,871 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $927,537 | 9,106 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $888,815 | 8,808 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $740,232 | 8,046 | Shares | Sole | 2023-04-25 | |
| 2022-12-31 | $665,975 | 7,341 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $562,778 | 7,404 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $691,032 | 8,175 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $904,965 | 10,313 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,049,377 | 11,997 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $1,136,496 | 13,897 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $1,074,259 | 11,774 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $708,629 | 8,290 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $736,931 | 7,804 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $664,983 | 7,647 | Shares | Sole | 2020-10-27 | |
| 2020-06-30 | $595,047 | 6,813 | Shares | Sole | 2020-07-16 | |
| 2020-03-31 | $443,168 | 5,375 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||